Andilab, Heidelyn .

HRN: 16-95-54  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
CEFUROXIME 500MG (TAB)
06/21/2025
06/28/2025
ORAL
500 MG/TAB
BID
S/P NSVD, THINLY MSAF
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: